TScan Therapeutics (TCRX) Net Equity Issued and Repurchased (2021 - 2023)
TScan Therapeutics' (TCRX) quarterly Net Equity Issued and Repurchased came in at -$186000.0 in Q3 2023, down 196.37% on a QoQ basis from $193000.0 in Q4 2022.
TScan Therapeutics (TCRX) Net Equity Issued and Repurchased (2021 - 2023) Analysis & Trends
TScan Therapeutics (TCRX) has 3 years of Net Equity Issued and Repurchased data on file, last reported at -$186000.0 in Q3 2023.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$186000.0 in Q3 2023; TTM through Dec 2024 was -$186000.0, a 2757.14% decrease from a year earlier, with the FY2024 full-year figure at $33.1 million, down 21.89% from the prior year.
- Net Equity Issued and Repurchased for Q3 2023 stood at -$186000.0, down from $193000.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for TCRX reached as high as $99.7 million in Q1 2021 and fell as low as -$186000.0 in Q3 2023.
- Historically, Net Equity Issued and Repurchased has averaged $33.2 million across 3 years, with a median of $193000.0 in 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 141.90 Mn |
| 10 | TScan Therapeutics | 100.59 Mn | -27.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -186,000.00 |
| Sep 30, 2023 | -186,000.00 |
| Dec 31, 2022 | 193,000.00 |
| Dec 31, 2022 | 193,000.00 |
| Mar 31, 2021 | 99.73 Mn |
| Mar 31, 2021 | 99.73 Mn |